ISSN: 1080-6059

Print this page  | Close Window

State Plans for Containment of Pandemic Influenza

Scott D. Holmberg,* Christine M. Layton,† George S. Ghneim,† and Diane K. Wagener‡
*Research Triangle Institute International, Atlanta, Georgia, USA; †Research Triangle Institute International, Research Triangle Park, North Carolina, USA; and ‡Research Triangle Institute International, Washington DC, USA
Vol. 12, No. 9 • September 2006


Download PDF (Download PDF 131 KB, 2 pages).

Appendix Table 2. Overview of 50 state plans for vaccination, surveillance, and containment of pandemic influenza*

State
Vaccination
Surveillance and detection
Community containment activities considered



ACIP priority groups
Other groups considered†
Clinics/hospitals/clinicians
Laboratories
Syndromic surveillance‡
International travelers
Voluntary self-isolation
School/institution closings
Institution/household quarantine
Contact vaccination/chemoprophylaxis

Alabama
Yes
 
Yes
Yes
         
Possible
Alaska
Yes
 
Yes
Yes
           
Arizona
Yes
 
Yes
Yes
   
Yes
     
Arkansas
Yes
Children 2–18 y of age
Yes
 
Nonprescription medicine use
 
Yes
Yes
Yes
 
California
(Yes)
(Yes)
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Colorado
Yes
 
Yes
Yes
           
Connecticut
Yes
 
Hospitals only
Yes
           
Delaware
Yes
Yes
Yes
Yes
         
Yes
Florida
Yes
Community service perssonnel† and preschoolers
Yes
Yes
     
Possible
 
Yes
Georgia
Yes
 
Yes
Yes
       
Possible
 
Hawaii
Yes
 
Yes
Yes
 
Yes
Yes
Possible
Possible
 
Idaho
Yes
 
Possible
Yes
Possible
 
Possible
Possible
   
Illinois
(Yes)
 
Yes
 
Possible
         
Indiana
Yes
Yes
Yes
Yes
   
Yes
Possible
Yes
Yes
Iowa
(Yes)
 
Yes
(Yes)
 
(Yes)
       
Kansas    
Yes
Yes
 
(Yes)
"Will follow generic…response plans.."
Kentucky
Yes
Yes
Yes
Yes
         
(Yes)
Louisiana
No pandemic influenza plan posted before Hurricane Katrina
Maine
Yes;
 
Yes
Yes
 
(Yes)
Yes
Possible
Yes
 
Maryland
Yes
 
Yes
Yes
 
(Yes)
       
Massachusetts
Yes
Yes
Yes
Yes
   
Yes
Yes
 
Yes
Michigan
Yes
(Yes)
Yes
Yes
 
Possible
Yes
Yes
   
Minnesota
Yes
 
Yes
Yes
Yes, in development
         
Mississippi
(Yes)
 
Yes
(Yes)
           
Missouri
Yes
Yes
Yes
Yes
           
Montana
Yes
 
Yes
Yes
           
Nebraska
(Yes)
 
Yes
Yes
Yes, in development
     
Possible
 
Nevada
(Yes)
 
Yes
Yes
   
Yes
     
New Hampshire
Yes
 
Yes
Yes
     
Yes
   
New Jersey
Yes
 
Yes
Yes
   
Yes
Yes
Yes
(Yes)
New Mexico
Yes
 
Yes
Yes
   
(Yes)
(Yes)
   
New York
(Yes)
(Yes)
Yes
Yes
Yes
Yes
Yes
Yes
Yes
(Yes)
North Carolina
Yes
(Yes)
Yes
Yes
Yes
 
(Yes)
(Yes)
(Yes)
Possible
North Dakota
Yes
(Yes)
Yes
Yes
           
Ohio
Yes
 
Yes
Yes
     
Possible
Possible
 
Oklahoma
Yes
 
Yes
Yes
     
Possible
Possible
 
Oregon
Yes
 
Yes
Yes
           
Pennsylvania
(Yes)
 
Yes
 
Pittsburgh
 
Yes
 
Possible
 
Rhode Island
Yes
                 
South Carolina
Yes
(Yes)
Yes
     
(Yes)
     
South Dakota
Yes
(Yes)
Yes
(Yes)
   
(Yes)
   
(Yes)
Tennessee
(Yes)
 
Yes
             
Texas
(Yes)
(Yes)
Yes
Yes
Yes, in development
     
Yes
 
Utah
Yes
 
(Yes)
       
Possible
   
Vermont
Yes
(Yes)
Yes
Yes
         
(Yes)
Virginia
(Yes)
 
Yes
Yes
Yes
         
Washington
(Yes)
 
(Yes)
             
West Virginia
Yes
(Yes)
               
Wisconsin
Yes
 
Yes
Yes
Possible
         
Wyoming
Yes
 
Yes
Yes
     
(Yes)
(Yes)
 

*ACIP, Advisory Committee on Immunization Practices; (Yes), a program was explicitly considered but not finalized in the state plan; Possible, a program was alluded to but not extensively considered.
†Other groups include nuclear power plant workers, telecommunications and public utility workers, and key government personnel.
‡Syndromic surveillance refers to the immediate electronic collection and reporting of patients in clinics, emergency departments, and other medical venues who have cough, fever, and other symptoms suggestive of influenza.

 

Download PDF (Download PDF 131 KB, 2 pages).

This page posted August 15, 2006
This page last reviewed August 15, 2006


Centers for Disease Control and Prevention,1600 Clifton Rd, Atlanta, GA 30333, U.S.A
Tel: (404) 639-3311 / Public Inquiries: (404) 639-3534 / (800) 311-3435